|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
EP2364734B1
(en)
*
|
2000-07-21 |
2017-09-06 |
ReVance Therapeutics, Inc. |
Multi-component biological transport systems
|
|
US6969514B2
(en)
*
|
2003-02-05 |
2005-11-29 |
Soll David B |
Method for treating elevated intraocular pressure, including glaucoma
|
|
AU2004222306A1
(en)
|
2003-03-17 |
2004-09-30 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
|
ES2351976T3
(es)
|
2003-04-29 |
2011-02-14 |
Avi Biopharma, Inc. |
Composiciones para mejorar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células.
|
|
KR101330775B1
(ko)
*
|
2004-03-03 |
2013-11-18 |
레반스 테라퓨틱스, 아이엔씨. |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US8092788B2
(en)
|
2004-03-03 |
2012-01-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
US20050288246A1
(en)
*
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
|
GB0413613D0
(en)
*
|
2004-06-17 |
2004-07-21 |
Univ London |
Small molecule carriers
|
|
WO2006010084A2
(en)
*
|
2004-07-06 |
2006-01-26 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cell nuclei
|
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
WO2006039163A2
(en)
|
2004-09-29 |
2006-04-13 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
|
JP2008514702A
(ja)
|
2004-09-29 |
2008-05-08 |
エーエムアール テクノロジー インコーポレイテッド |
新規シクロスポリン類似体およびそれらの薬学的使用
|
|
WO2006041631A2
(en)
|
2004-10-06 |
2006-04-20 |
Amr Technology, Inc. |
Novel cyclosporin alkynes and their utility as pharmaceutical agents
|
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
|
ZA200707352B
(en)
|
2005-03-03 |
2009-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
WO2006094193A2
(en)
*
|
2005-03-03 |
2006-09-08 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of an oligopeptide
|
|
GB2427360A
(en)
*
|
2005-06-22 |
2006-12-27 |
Complex Biosystems Gmbh |
Aliphatic prodrug linker
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
US7700565B2
(en)
|
2005-09-23 |
2010-04-20 |
Nitto Denko Corporation |
Peptide nucleic acid based guanidinium compounds
|
|
WO2007038169A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues
|
|
WO2007038172A2
(en)
*
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
|
EP1948230A4
(en)
*
|
2005-11-17 |
2010-03-10 |
Revance Therapeutics Inc |
COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULIN TOXINES WITH A REDUCED NUMBER OF NON-TOXIC PROTEINS
|
|
BRPI0620811A2
(pt)
*
|
2005-12-30 |
2011-11-22 |
Revance Therapeutics Inc |
heterÈmeros de arginina para administração tópica
|
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
SG188908A1
(en)
|
2006-07-14 |
2013-04-30 |
Wisconsin Alumni Res Found |
Adsorptive membranes for trapping viruses
|
|
WO2008037463A2
(en)
*
|
2006-09-27 |
2008-04-03 |
Paolo Botti |
Means and methods of enhancing delivery to biological systems
|
|
EP1905454A1
(en)
*
|
2006-09-27 |
2008-04-02 |
Paolo Botti |
Formulations comprising cyclic compounds
|
|
JP2010514781A
(ja)
*
|
2006-12-29 |
2010-05-06 |
ルバンス セラピュティックス インク． |
Ｈｉｖ−ｔａｔに由来するポリペプチド断片を用いて安定化されるボツリヌス毒素を局所適用及び経皮送達する組成物及び方法
|
|
JP2010514779A
(ja)
*
|
2006-12-29 |
2010-05-06 |
ルバンス セラピュティックス インク． |
逆配列ｈｉｖ−ｔａｔポリペプチドを用いる輸送分子
|
|
EP2129388B1
(en)
*
|
2007-02-23 |
2012-09-12 |
The Research Foundation Of State University Of New York |
Rna targeting compounds and methods for making and using same
|
|
US9260476B2
(en)
|
2007-02-23 |
2016-02-16 |
The Research Foundation For The State University Of New York |
RNA targeting compounds and methods for making and using same
|
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
EP2144633B1
(en)
*
|
2007-04-23 |
2014-07-16 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
WO2014064687A1
(en)
|
2012-10-22 |
2014-05-01 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
AU2008271050B2
(en)
*
|
2007-06-29 |
2014-11-06 |
Sarepta Therapeutics, Inc. |
Tissue specific peptide conjugates and methods
|
|
EP2178549B1
(en)
*
|
2007-07-26 |
2016-09-14 |
Revance Therapeutics, Inc. |
Antimicrobial peptide and compositions thereof
|
|
US7842762B2
(en)
*
|
2007-08-08 |
2010-11-30 |
Ppg Industries Ohio, Inc. |
Electrodepositable coating composition containing a cyclic guanidine
|
|
US20110160146A1
(en)
*
|
2008-02-07 |
2011-06-30 |
National Institute of Health (NIH) |
Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance
|
|
US20100143437A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Morris Edward J |
Implantable analgesic
|
|
WO2010111533A2
(en)
*
|
2009-03-25 |
2010-09-30 |
Kai Pharmaceuticals, Inc. |
Transdermal delivery of pkc modulatory peptides through microporated skin
|
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
CN103118692A
(zh)
|
2010-04-26 |
2013-05-22 |
Atyr医药公司 |
与半胱氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2797362C
(en)
|
2010-04-27 |
2020-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
CN103097524B
(zh)
|
2010-04-28 |
2016-08-03 |
Atyr医药公司 |
与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
AU2011248457B2
(en)
|
2010-04-29 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
|
|
US8986680B2
(en)
|
2010-04-29 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
|
ES2623805T3
(es)
|
2010-05-03 |
2017-07-12 |
Atyr Pharma, Inc. |
Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas
|
|
EP2566496B1
(en)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
|
CN103096925A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CN102985103A
(zh)
|
2010-05-04 |
2013-03-20 |
Atyr医药公司 |
与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2799197C
(en)
|
2010-05-14 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
CA2800375C
(en)
|
2010-05-27 |
2021-03-09 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
|
CN103118694B
(zh)
|
2010-06-01 |
2016-08-03 |
Atyr医药公司 |
与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
|
WO2013036532A1
(en)
*
|
2011-09-06 |
2013-03-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Amphipathic co-oligomers for the delivery of sirna
|
|
US9816066B2
(en)
|
2012-04-24 |
2017-11-14 |
The Regents Of The University Of California |
Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
|
|
CN102863357B
(zh)
*
|
2012-09-20 |
2014-01-01 |
华中农业大学 |
具有植物生长调节活性的化合物及其制备方法
|
|
US20140120077A1
(en)
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and Methods for Safe Treatment of Rhinitis
|
|
US9068089B2
(en)
|
2013-03-15 |
2015-06-30 |
Ppg Industries Ohio, Inc. |
Phenolic admix for electrodepositable coating composition containing a cyclic guanidine
|
|
US9688874B2
(en)
|
2013-10-25 |
2017-06-27 |
Ppg Industries Ohio, Inc. |
Method of making a bicyclic guanidine-cured acrylic coating
|
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
RS59119B1
(sr)
|
2014-05-21 |
2019-09-30 |
Entrada Therapeutics Inc |
Peptidi koji prodiru u ćelije i postupci za njihovo pravljenje i upotrebu
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US10383912B2
(en)
*
|
2014-08-18 |
2019-08-20 |
Washington State University |
Tunable pH-sensitive linker for controlled drug release
|
|
WO2016033368A1
(en)
|
2014-08-27 |
2016-03-03 |
Ohio State Innovation Foundation |
Improved peptidyl calcineurin inhibitors
|
|
US9854806B2
(en)
|
2015-05-19 |
2018-01-02 |
International Business Machines Corporation |
Antimicrobial guanidinium and thiouronium functionalized polymers
|
|
WO2016196897A1
(en)
|
2015-06-04 |
2016-12-08 |
Sarepta Therapeutics, Inc. |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
|
EP3490562B1
(en)
|
2016-07-27 |
2025-09-03 |
The Board of Trustees of the Leland Stanford Junior University |
Immolative cell-penetrating complexes for nucleic acid delivery
|
|
KR102810425B1
(ko)
|
2016-12-19 |
2025-05-21 |
사렙타 쎄러퓨틱스 인코퍼레이티드 |
근육 이상증에 대한 엑손 스킵핑 올리고머 결합체
|
|
CU20190092A7
(es)
*
|
2017-05-19 |
2020-10-20 |
Lunella Biotech Inc |
Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
|
|
CA3078504A1
(en)
|
2017-10-04 |
2019-04-11 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
|
EP3717015A4
(en)
|
2017-12-01 |
2021-07-28 |
Lunella Biotech, Inc. |
REPURPOSCINS: TARGET MITOCHONDRIAL BIOGENESIS INHIBITORS TO ERADICATE CARCINOUS STEM CELLS
|
|
US11793884B2
(en)
|
2018-01-29 |
2023-10-24 |
Ohio State Innovation Foundation |
Cyclic peptidyl inhibitors of CAL-PDZ binding domain
|
|
WO2019148194A2
(en)
|
2018-01-29 |
2019-08-01 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-nfat interaction
|
|
TW201945014A
(zh)
|
2018-02-22 |
2019-12-01 |
美商安卓達治療股份有限公司 |
用於治療粒線體性神經胃腸腦病變之組合物及方法
|
|
JP2021519841A
(ja)
|
2018-03-30 |
2021-08-12 |
ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ |
ペンダントクロモフォアを有する水溶性ポリマー色素
|
|
US11987647B2
(en)
|
2018-05-09 |
2024-05-21 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
MX2021002833A
(es)
|
2018-09-27 |
2021-05-27 |
Biophysics Pharma Inc |
Sistema de suministro de farmaco transdermico.
|
|
US10953039B2
(en)
|
2018-09-27 |
2021-03-23 |
International Business Machines Corporation |
Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
|
|
US12246098B2
(en)
|
2018-09-27 |
2025-03-11 |
BioPhysics Pharma, Inc. |
Trans-epithelial membrane drug delivery system
|
|
WO2020160511A1
(en)
|
2019-02-01 |
2020-08-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Immolative cell-penetrating complexes for nucleic acid delivery to the lung
|
|
EP4106876B1
(en)
|
2020-02-18 |
2025-09-17 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI874791B
(zh)
|
2020-02-18 |
2025-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
JP2023532736A
(ja)
*
|
2020-07-02 |
2023-07-31 |
ユニバーシティー オブ ヒューストン システム |
血液脳関門を通過する薬物送達のための化合物
|
|
IL302744A
(en)
|
2020-11-24 |
2023-07-01 |
Lyell Immunopharma Inc |
Methods for production, total preparations and methods of using regenerated T cells
|
|
KR102923359B1
(ko)
|
2021-04-16 |
2026-02-05 |
길리애드 사이언시즈, 인코포레이티드 |
아미드를 사용한 카르바뉴클레오시드를 제조하는 방법
|
|
EP4387977A1
(en)
|
2021-08-18 |
2024-06-26 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
EP4155349A1
(en)
|
2021-09-24 |
2023-03-29 |
Becton, Dickinson and Company |
Water-soluble yellow green absorbing dyes
|